These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18523279)

  • 1. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor.
    Saunderson SC; Schuberth PC; Dunn AC; Miller L; Hock BD; MacKay PA; Koch N; Jack RW; McLellan AD
    J Immunol; 2008 Jun; 180(12):8146-52. PubMed ID: 18523279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-bound antigen is targeted to exosomes in human follicular lymphoma B-cells.
    Rialland P; Lankar D; Raposo G; Bonnerot C; Hubert P
    Biol Cell; 2006 Aug; 98(8):491-501. PubMed ID: 16677129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine B1 B cells require IL-5 for optimal T cell-dependent activation.
    Erickson LD; Foy TM; Waldschmidt TJ
    J Immunol; 2001 Feb; 166(3):1531-9. PubMed ID: 11160193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40.
    Evans DE; Munks MW; Purkerson JM; Parker DC
    J Immunol; 2000 Jan; 164(2):688-97. PubMed ID: 10623811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome release by primary B cells.
    McLellan AD
    Crit Rev Immunol; 2009; 29(3):203-17. PubMed ID: 19538135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12.
    Shirota H; Sano K; Hirasawa N; Terui T; Ohuchi K; Hattori T; Tamura G
    J Immunol; 2002 Jul; 169(2):787-94. PubMed ID: 12097381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocytes secrete antigen-presenting vesicles.
    Raposo G; Nijman HW; Stoorvogel W; Liejendekker R; Harding CV; Melief CJ; Geuze HJ
    J Exp Med; 1996 Mar; 183(3):1161-72. PubMed ID: 8642258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
    Clatza A; Bonifaz LC; Vignali DA; Moreno J
    J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognate B cell signaling via MHC class II: differential regulation of B cell antigen receptor and MHC class II/Ig-alpha beta signaling by CD22.
    Mills DM; Stolpa JC; Cambier JC
    J Immunol; 2004 Jan; 172(1):195-201. PubMed ID: 14688326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells.
    Snyder CM; Zhang X; Wysocki LJ
    J Immunol; 2002 Apr; 168(8):3865-73. PubMed ID: 11937540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell activation regulates exosomal HLA production.
    Arita S; Baba E; Shibata Y; Niiro H; Shimoda S; Isobe T; Kusaba H; Nakano S; Harada M
    Eur J Immunol; 2008 May; 38(5):1423-34. PubMed ID: 18425730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG1 production by sIgD+ splenic B cells and peritoneal B-1 cells in response to IL-5 and CD38 ligation.
    Yasue T; Baba M; Mori S; Mizoguchi C; Uehara S; Takatsu K
    Int Immunol; 1999 Jun; 11(6):915-23. PubMed ID: 10360965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
    Bishop GA; Warren WD; Berton MT
    Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes.
    Skokos D; Le Panse S; Villa I; Rousselle JC; Peronet R; David B; Namane A; Mécheri S
    J Immunol; 2001 Jan; 166(2):868-76. PubMed ID: 11145662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
    D'Orazio TJ; Mayhew E; Niederkorn JY
    J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.
    Hokazono Y; Adachi T; Wabl M; Tada N; Amagasa T; Tsubata T
    J Immunol; 2003 Aug; 171(4):1835-43. PubMed ID: 12902484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell.
    Kasprowicz DJ; Kohm AP; Berton MT; Chruscinski AJ; Sharpe A; Sanders VM
    J Immunol; 2000 Jul; 165(2):680-90. PubMed ID: 10878340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.
    Cho S; Conrad DH
    Int Immunol; 1997 Feb; 9(2):239-48. PubMed ID: 9040006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
    Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
    J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line.
    Cerutti A; Zan H; Schaffer A; Bergsagel L; Harindranath N; Max EE; Casali P
    J Immunol; 1998 Mar; 160(5):2145-57. PubMed ID: 9498752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.